RAQUEL RODRIGUEZ: Open Payments
NPI 1306421797 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$789 in 31 payments from 13 companies in 2025. Trend: 2023 $723 · 2024 $1,047 · 2025 $789
Food & beverage: $704Education: $85
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $173 |
| Lilly USA, LLC | 5 | $103 |
| SEAGEN INC. | 1 | $85 |
| Daiichi Sankyo Inc. | 3 | $81 |
| PFIZER INC. | 3 | $64 |
| Novartis Pharmaceuticals Corporation | 2 | $59 |
| Merck Sharp & Dohme LLC | 3 | $58 |
| Tempus AI, Inc | 2 | $48 |
| Gilead Sciences, Inc. | 1 | $34 |
| Janssen Biotech, Inc. | 1 | $26 |
Products named: Enhertu, VERZENIO, IBRANCE, KISQALI, XT CDX, LYNPARZA, KEYTRUDA, DATROWAY.
Industry payments across FL — which companies pay providers there.
